Example of Aging Clinical and Experimental Research format
Recent searches

Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
Look Inside
Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format Example of Aging Clinical and Experimental Research format
Sample paper formatted on SciSpace - SciSpace
This content is only for preview purposes. The original open access content can be found here.
open access Open Access

Aging Clinical and Experimental Research — Template for authors

Publisher: Springer
Categories Rank Trend in last 3 yrs
Geriatrics and Gerontology #23 of 99 up up by 26 ranks
Aging #16 of 35 up up by 6 ranks
journal-quality-icon Journal quality:
High
calendar-icon Last 4 years overview: 885 Published Papers | 4537 Citations
indexed-in-icon Indexed in: Scopus
last-updated-icon Last updated: 05/06/2020
Related journals
Insights
General info
Top papers
Popular templates
Get started guide
Why choose from SciSpace
FAQ

Related Journals

open access Open Access
recommended Recommended

Springer

Quality:  
High
CiteRatio: 7.0
SJR: 1.227
SNIP: 1.238
open access Open Access
recommended Recommended

Springer

Quality:  
High
CiteRatio: 9.5
SJR: 1.883
SNIP: 1.472
open access Open Access
recommended Recommended

Elsevier

Quality:  
High
CiteRatio: 8.1
SJR: 2.081
SNIP: 1.146
open access Open Access

SAGE

Quality:  
High
CiteRatio: 3.6
SJR: 0.787
SNIP: 1.386

Journal Performance & Insights

Impact Factor

CiteRatio

Determines the importance of a journal by taking a measure of frequency with which the average article in a journal has been cited in a particular year.

A measure of average citations received per peer-reviewed paper published in the journal.

2.697

16% from 2018

Impact factor for Aging Clinical and Experimental Research from 2016 - 2019
Year Value
2019 2.697
2018 2.331
2017 2.121
2016 1.394
graph view Graph view
table view Table view

5.1

19% from 2019

CiteRatio for Aging Clinical and Experimental Research from 2016 - 2020
Year Value
2020 5.1
2019 4.3
2018 3.5
2017 2.7
2016 2.1
graph view Graph view
table view Table view

insights Insights

  • Impact factor of this journal has increased by 16% in last year.
  • This journal’s impact factor is in the top 10 percentile category.

insights Insights

  • CiteRatio of this journal has increased by 19% in last years.
  • This journal’s CiteRatio is in the top 10 percentile category.

SCImago Journal Rank (SJR)

Source Normalized Impact per Paper (SNIP)

Measures weighted citations received by the journal. Citation weighting depends on the categories and prestige of the citing journal.

Measures actual citations received relative to citations expected for the journal's category.

0.911

10% from 2019

SJR for Aging Clinical and Experimental Research from 2016 - 2020
Year Value
2020 0.911
2019 0.825
2018 0.75
2017 0.67
2016 0.491
graph view Graph view
table view Table view

1.245

11% from 2019

SNIP for Aging Clinical and Experimental Research from 2016 - 2020
Year Value
2020 1.245
2019 1.122
2018 0.823
2017 0.688
2016 0.575
graph view Graph view
table view Table view

insights Insights

  • SJR of this journal has increased by 10% in last years.
  • This journal’s SJR is in the top 10 percentile category.

insights Insights

  • SNIP of this journal has increased by 11% in last years.
  • This journal’s SNIP is in the top 10 percentile category.

Aging Clinical and Experimental Research

Guideline source: View

All company, product and service names used in this website are for identification purposes only. All product names, trademarks and registered trademarks are property of their respective owners.

Use of these names, trademarks and brands does not imply endorsement or affiliation. Disclaimer Notice

Springer

Aging Clinical and Experimental Research

Approved by publishing and review experts on SciSpace, this template is built as per for Aging Clinical and Experimental Research formatting guidelines as mentioned in Springer author instructions. The current version was created on and has been used by 231 authors to write and format their manuscripts to this journal.

i
Last updated on
05 Jun 2020
i
ISSN
1606-8610
i
Open Access
Hybrid
i
Sherpa RoMEO Archiving Policy
White faq
i
Plagiarism Check
Available via Turnitin
i
Endnote Style
Download Available
i
Citation Type
Author Year
(Blonder et al, 1982)
i
Bibliography Example
Beenakker CWJ (2006) Specular andreev reflection in graphene. Phys Rev Lett 97(6):067,007, URL 10.1103/PhysRevLett.97.067007

Top papers written in this journal

open accessOpen access Journal Article DOI: 10.1007/S40520-020-01570-8
The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality.
Petre Cristian Ilie1, Simina Stefanescu2, Lee Smith3

Abstract:

WHO declared SARS-CoV-2 a global pandemic. The present aim was to propose an hypothesis that there is a potential association between mean levels of vitamin D in various countries with cases and mortality caused by COVID-19. The mean levels of vitamin D for 20 European countries and morbidity and mortality caused by COVID-19 ... WHO declared SARS-CoV-2 a global pandemic. The present aim was to propose an hypothesis that there is a potential association between mean levels of vitamin D in various countries with cases and mortality caused by COVID-19. The mean levels of vitamin D for 20 European countries and morbidity and mortality caused by COVID-19 were acquired. Negative correlations between mean levels of vitamin D (average 56 mmol/L, STDEV 10.61) in each country and the number of COVID-19 cases/1 M (mean 295.95, STDEV 298.7, and mortality/1 M (mean 5.96, STDEV 15.13) were observed. Vitamin D levels are severely low in the aging population especially in Spain, Italy and Switzerland. This is also the most vulnerable group of the population in relation to COVID-19. It should be advisable to perform dedicated studies about vitamin D levels in COVID-19 patients with different degrees of disease severity. read more read less

Topics:

vitamin D deficiency (61%)61% related to the paper, Vitamin D and neurology (57%)57% related to the paper, Population (53%)53% related to the paper
View PDF
595 Citations
open accessOpen access Journal Article DOI: 10.1007/BF03324754
Men: good health and high mortality. Sex differences in health and aging*
Anna Oksuzyan1, Anna Oksuzyan2, Knud Juel1, James W. Vaupel2, Kaare Christensen1

Abstract:

This review examines sex differences in health and survival, with a focus on the Nordic countries. There is a remarkable discrepancy between the health and survival of the sexes: men are physically stronger and have fewer disabilities, but have substantially higher mortality at all ages compared with women: the so-called male... This review examines sex differences in health and survival, with a focus on the Nordic countries. There is a remarkable discrepancy between the health and survival of the sexes: men are physically stronger and have fewer disabilities, but have substantially higher mortality at all ages compared with women: the so-called male-female health-survival paradox. A number of proposed explanations for this paradox are rooted in biological, social, and psychological interpretations. It is likely to be due to multiple causes that include fundamental biological differences between the sexes such as genetic factors, immune system responses, hormones, and disease patterns. Behavioral differences such as risk-taking and reluctance to seek and comply with medical treatment may also play a role. Another consideration is that part of the difference may be due to methodological challenges, such as selective non-participation and under-reporting of health problems, and delayed seeking of treatment by men. The Nordic countries provide a unique opportunity for such studies, as they have good-quality data in their national health registers, which cover the whole population, and a long tradition of high participation rates in surveys. read more read less

Topics:

Population (52%)52% related to the paper
495 Citations
Book Chapter DOI: 10.1016/B978-012369391-4/50051-5
Models, definitions, and criteria of frailty.
David B. Hogan1, Chris MacKnight, Howard Bergman

Abstract:

This chapter will examine the current state of research on frailty. A number of competing and complementary models for its development will be described. This will be followed by a working definition of frailty. Finally, criteria for the identification of frailty in older individuals will be discussed. Promising future direct... This chapter will examine the current state of research on frailty. A number of competing and complementary models for its development will be described. This will be followed by a working definition of frailty. Finally, criteria for the identification of frailty in older individuals will be discussed. Promising future directions for research will be noted throughout the chapter. The aim is to provide useful background information about frailty for researchers interested in the field. It is an area of inquiry still early in its evolution. read more read less
View PDF
471 Citations
Journal Article DOI: 10.1007/BF03324546
A longitudinal study integrating population, care and social services data. The Swedish National study on Aging and Care (SNAC).

Abstract:

Background and aims: A large, national, long-term, longitudinal, multi-purpose study has been launched in Sweden - the Swedish National study on Aging and Care (SNAC). The study involves four resea ... Background and aims: A large, national, long-term, longitudinal, multi-purpose study has been launched in Sweden - the Swedish National study on Aging and Care (SNAC). The study involves four resea ... read more read less

Topics:

Population (52%)52% related to the paper, Health care (52%)52% related to the paper, Longitudinal study (50%)50% related to the paper
409 Citations
Journal Article DOI: 10.1007/BF03339822
Therapeutic equivalence of alendronate 70 mg once-weekly and alendronate 10 mg daily in the treatment of osteoporosis

Abstract:

Dosing convenience is a key element in the effective management of any chronic disease, and is particularly important in the long-term management of osteoporosis. Less frequent dosing with any medication may enhance compliance, thereby maximizing the effectiveness of therapy. Animal data support the rationale that once-weekly... Dosing convenience is a key element in the effective management of any chronic disease, and is particularly important in the long-term management of osteoporosis. Less frequent dosing with any medication may enhance compliance, thereby maximizing the effectiveness of therapy. Animal data support the rationale that once-weekly dosing with alendronate 70 mg (7 times the daily oral treatment dose) could provide similar efficacy to daily dosing with alendronate 10 mg due to its long duration of effect in bone. In addition, dog studies suggest that the potential for esophageal irritation, observed with daily oral bisphosphonates, may be substantially reduced with once-weekly dosing. This dosing regimen would provide patients with increased convenience and would be likely to enhance patient compliance. We compared the efficacy and safety of treatment with oral once-weekly alendronate 70 mg (N=519), twice-weekly alendronate 35 mg (N=369), and daily alendronate 10 mg (N=370) in a one-year, double- blind, multicenter study of postmenopausal women (ages 42 to 95) with osteoporosis (bone mineral density [BMD] of either lumbar spine or femoral neck at least 2.5 SDs below peak premenopausal mean, or prior vertebral or hip fracture). The primary efficacy endpoint was the comparability of increases in lumbar spine BMD, using strict pre-defined equivalence criteria. Secondary endpoints included changes in BMD at the hip and total body and rate of bone turnover, as assessed by biochemical markers. Both of the new regimens fully satisfied the equivalence criteria relative to daily therapy. Mean increases in lumbar spine BMD at 12 months were: 5.1% (95% CI 4.8, 5.4) in the 70 mg once-weekly group, 5.2% (4.9, 5.6) in the 35 mg twice-weekly group, and 5.4% (5.0, 5.8) in the 10 mg daily treatment group. Increases in BMD at the total hip, femoral neck, trochanter, and total body were similar for the three dosing regimens. All three treatment groups similarly reduced biochemical markers of bone resorption (urinary N-telopeptides of type I collagen) and bone formation (serum bone-specific alkaline phosphatase) into the middle of the premenopausal reference range. All treatment regimens were well tolerated with a similar incidence of upper GI adverse experiences. There were fewer serious upper GI adverse experiences and a trend toward a lower incidence of esophageal events in the once-weekly dosing group compared to the daily dosing group. These data are consistent with preclinical animal models, and suggest that once-weekly dosing has the potential for improved upper GI tolerability. Clinical fractures, captured as adverse experiences, were similar among the groups. We conclude that the alendronate 70 mg once-weekly dosing regimen will provide patients with a more convenient, therapeutically equivalent alternative to daily dosing, and may enhance compliance and long-term persistence with therapy. read more read less

Topics:

Dosing (55%)55% related to the paper, Osteoporosis (55%)55% related to the paper, Animal data (52%)52% related to the paper, Tolerability (51%)51% related to the paper, Hip fracture (50%)50% related to the paper
385 Citations
Author Pic

SciSpace is a very innovative solution to the formatting problem and existing providers, such as Mendeley or Word did not really evolve in recent years.

- Andreas Frutiger, Researcher, ETH Zurich, Institute for Biomedical Engineering

Get MS-Word and LaTeX output to any Journal within seconds
1
Choose a template
Select a template from a library of 40,000+ templates
2
Import a MS-Word file or start fresh
It takes only few seconds to import
3
View and edit your final output
SciSpace will automatically format your output to meet journal guidelines
4
Submit directly or Download
Submit to journal directly or Download in PDF, MS Word or LaTeX

(Before submission check for plagiarism via Turnitin)

clock Less than 3 minutes

What to expect from SciSpace?

Speed and accuracy over MS Word

''

With SciSpace, you do not need a word template for Aging Clinical and Experimental Research.

It automatically formats your research paper to Springer formatting guidelines and citation style.

You can download a submission ready research paper in pdf, LaTeX and docx formats.

Time comparison

Time taken to format a paper and Compliance with guidelines

Plagiarism Reports via Turnitin

SciSpace has partnered with Turnitin, the leading provider of Plagiarism Check software.

Using this service, researchers can compare submissions against more than 170 million scholarly articles, a database of 70+ billion current and archived web pages. How Turnitin Integration works?

Turnitin Stats
Publisher Logos

Freedom from formatting guidelines

One editor, 100K journal formats – world's largest collection of journal templates

With such a huge verified library, what you need is already there.

publisher-logos

Easy support from all your favorite tools

Automatically format and order your citations and bibliography in a click.

SciSpace allows imports from all reference managers like Mendeley, Zotero, Endnote, Google Scholar etc.

Frequently asked questions

1. Can I write Aging Clinical and Experimental Research in LaTeX?

Absolutely not! Our tool has been designed to help you focus on writing. You can write your entire paper as per the Aging Clinical and Experimental Research guidelines and auto format it.

2. Do you follow the Aging Clinical and Experimental Research guidelines?

Yes, the template is compliant with the Aging Clinical and Experimental Research guidelines. Our experts at SciSpace ensure that. If there are any changes to the journal's guidelines, we'll change our algorithm accordingly.

3. Can I cite my article in multiple styles in Aging Clinical and Experimental Research?

Of course! We support all the top citation styles, such as APA style, MLA style, Vancouver style, Harvard style, and Chicago style. For example, when you write your paper and hit autoformat, our system will automatically update your article as per the Aging Clinical and Experimental Research citation style.

4. Can I use the Aging Clinical and Experimental Research templates for free?

Sign up for our free trial, and you'll be able to use all our features for seven days. You'll see how helpful they are and how inexpensive they are compared to other options, Especially for Aging Clinical and Experimental Research.

5. Can I use a manuscript in Aging Clinical and Experimental Research that I have written in MS Word?

Yes. You can choose the right template, copy-paste the contents from the word document, and click on auto-format. Once you're done, you'll have a publish-ready paper Aging Clinical and Experimental Research that you can download at the end.

6. How long does it usually take you to format my papers in Aging Clinical and Experimental Research?

It only takes a matter of seconds to edit your manuscript. Besides that, our intuitive editor saves you from writing and formatting it in Aging Clinical and Experimental Research.

7. Where can I find the template for the Aging Clinical and Experimental Research?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Aging Clinical and Experimental Research's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

8. Can I reformat my paper to fit the Aging Clinical and Experimental Research's guidelines?

Of course! You can do this using our intuitive editor. It's very easy. If you need help, our support team is always ready to assist you.

9. Aging Clinical and Experimental Research an online tool or is there a desktop version?

SciSpace's Aging Clinical and Experimental Research is currently available as an online tool. We're developing a desktop version, too. You can request (or upvote) any features that you think would be helpful for you and other researchers in the "feature request" section of your account once you've signed up with us.

10. I cannot find my template in your gallery. Can you create it for me like Aging Clinical and Experimental Research?

Sure. You can request any template and we'll have it setup within a few days. You can find the request box in Journal Gallery on the right side bar under the heading, "Couldn't find the format you were looking for like Aging Clinical and Experimental Research?”

11. What is the output that I would get after using Aging Clinical and Experimental Research?

After writing your paper autoformatting in Aging Clinical and Experimental Research, you can download it in multiple formats, viz., PDF, Docx, and LaTeX.

12. Is Aging Clinical and Experimental Research's impact factor high enough that I should try publishing my article there?

To be honest, the answer is no. The impact factor is one of the many elements that determine the quality of a journal. Few of these factors include review board, rejection rates, frequency of inclusion in indexes, and Eigenfactor. You need to assess all these factors before you make your final call.

13. What is Sherpa RoMEO Archiving Policy for Aging Clinical and Experimental Research?

SHERPA/RoMEO Database

We extracted this data from Sherpa Romeo to help researchers understand the access level of this journal in accordance with the Sherpa Romeo Archiving Policy for Aging Clinical and Experimental Research. The table below indicates the level of access a journal has as per Sherpa Romeo's archiving policy.

RoMEO Colour Archiving policy
Green Can archive pre-print and post-print or publisher's version/PDF
Blue Can archive post-print (ie final draft post-refereeing) or publisher's version/PDF
Yellow Can archive pre-print (ie pre-refereeing)
White Archiving not formally supported
FYI:
  1. Pre-prints as being the version of the paper before peer review and
  2. Post-prints as being the version of the paper after peer-review, with revisions having been made.

14. What are the most common citation types In Aging Clinical and Experimental Research?

The 5 most common citation types in order of usage for Aging Clinical and Experimental Research are:.

S. No. Citation Style Type
1. Author Year
2. Numbered
3. Numbered (Superscripted)
4. Author Year (Cited Pages)
5. Footnote

15. How do I submit my article to the Aging Clinical and Experimental Research?

It is possible to find the Word template for any journal on Google. However, why use a template when you can write your entire manuscript on SciSpace , auto format it as per Aging Clinical and Experimental Research's guidelines and download the same in Word, PDF and LaTeX formats? Give us a try!.

16. Can I download Aging Clinical and Experimental Research in Endnote format?

Yes, SciSpace provides this functionality. After signing up, you would need to import your existing references from Word or Bib file to SciSpace. Then SciSpace would allow you to download your references in Aging Clinical and Experimental Research Endnote style according to Elsevier guidelines.

Fast and reliable,
built for complaince.

Instant formatting to 100% publisher guidelines on - SciSpace.

Available only on desktops 🖥

No word template required

Typset automatically formats your research paper to Aging Clinical and Experimental Research formatting guidelines and citation style.

Verifed journal formats

One editor, 100K journal formats.
With the largest collection of verified journal formats, what you need is already there.

Trusted by academicians

I spent hours with MS word for reformatting. It was frustrating - plain and simple. With SciSpace, I can draft my manuscripts and once it is finished I can just submit. In case, I have to submit to another journal it is really just a button click instead of an afternoon of reformatting.

Andreas Frutiger
Researcher & Ex MS Word user
Use this template